Medical and surgical management of malignant pleuritis

Symposium
Chairs: R. Huber (Munich, Germany), D. Subotic (Belgrade, Serbia and Montenegro)
Aims: The audience should get clear information on several frequent clinical situations:
• how far should we investigate a patient with a malignant pleural effusion and without intrathoracic primary tumor?
• can contemporary chemotherapy prevent the recurrence of a malignant effusion?
• which is the most efficient type of pleurodesis?
• how can we manage the œtrapped lung?
• what are the new standards for treatment of mesothelioma?
• is radical surgery of mesothelioma still an issue? Target audience: Pulmonary physicians, pulmonary oncologists, thoracic surgeons.

Epidemiology and clinical problems of orphant pleural adenocarcinoma J. Brechot (Bobigny, France)
An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma J. Sculier (Brussels, Belgium)
Surgical problems with the malignant pleural space H. Ris (Lausanne, Switzerland)